Global Narcotic Drugs Market
Global Narcotic Drugs Market

Narcotic Drugs Comprehensive Study by Type (Opium, Heroin, Demerol, Darvon, Others), Types (Stimulants (E.G. Cocaine), Depressants (E.G. Alcohol), Opium-Related Painkillers (E.G. Heroin), Hallucinogens (E.G. Lsd)), Distribution Channel (Offline, Online, Direct Consumer Sell), End-user (Male, Female), Material (Morphine, Codeine) Players and Region - Global Market Outlook to 2027

Narcotic Drugs Market Segmented into XX Submarkets. | Forecast Years: 2022- 2027  

Jun 2022 Edition 214 Pages 81 Tables & Figures
  • Summary
  • Market Segments
  • Table of Content
  • List of Tables & Figures
  • Companies Mentioned
About Narcotic Drugs
Narcotic Drugs is type of drugs which is used to treat moderate to severe pain. Narcotics are like opiates such as morphine and codeine, but are not made from opium. They bind to opioid receptors in the central nervous system. Narcotics are now called opioids. In medicine, a narcotic drug is chemical agent that brings coma, or insensibility to pain also called narcotic analgesic. Narcotic drug that produces analgesia which means pain relief as well as narcosis which means state of sleep and addiction that means physical dependence on the drug. In some people narcotics also produce euphoria a feeling of great joy. Narcotic drugs are the addictive substance that reduces the patientís perception of pain and brings joy. These drugs are oldest and strongest pain-relieving agents which cause depression of central nervous system and produce sleeping state in patients.

AttributesDetails
Study Period2017-2027
Base Year2021
UnitValue (USD Million)


Global market is highly competitive and consists of a limited number of providers who compete with each other. The intense competition, changing consumer expenditure patterns, frequent changes in consumer preferences. And the competition consists the company profit and company global market strategic. The Global market of Narcotic Drugs is including the high market capturing key player. Analyst at AMA Research estimates that United States Players will contribute the maximum growth to Global Narcotic Drugs market throughout the forecasted period. Established and emerging Players should take a closer view at their existing organizations and reinvent traditional business and operating models to adapt to the future.

Johnson & Johnson (United States), Roche (Switzerland), Novartis Ag (Switzerland), Merck & Co. (United States), Pfizer (United States), Merck (United States), Glaxosmithkline (United Kingdom), Sanofi (Paris), Sun Pharma (India) and Glaxosmithkline Australia Pty Ltd. (Australia) are some of the key players that are part of study coverage. Additionally, the Players which are also part of the research coverage are Celanese Chemicals (United States), Bedoukian Research Inc. (United States) and Eastman Chemical Company. (United States).

Segmentation Overview
AMA Research has segmented the market of Global Narcotic Drugs market by Type (Opium, Heroin, Demerol, Darvon and Others) and Region.

On the basis of geography, the market of Narcotic Drugs has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). If we see Market by Types, the sub-segment i.e. Stimulants (E.G. Cocaine) will boost the Narcotic Drugs market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth. If we see Market by Distribution Channel, the sub-segment i.e. Offline will boost the Narcotic Drugs market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth. If we see Market by End-user, the sub-segment i.e. Male will boost the Narcotic Drugs market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth. If we see Market by Material, the sub-segment i.e. Morphine will boost the Narcotic Drugs market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth.

Market Leaders and their expansionary development strategies
On May 24 2022 - pfizer inc. And biohaven pharmaceutical announced that pfizer will acquire biohaven after years of collaborative drug development, improving access to medicine used to treat migraines. Pfizer had already owned a portion of biohaven before this new agreement, and the acquisition will transfer ownership of several drugs to pfizer for future commercialization. According to the merge and acquisition Pfizer will obtain rights to commercialize NURTEC ODT, a compound used to treat acute migraine, and another migraine medication called zavegepant. Pfizerís and Biohaven will continue to focus on migraine treatment drug development.
In 2021 CRIMJUST launched the first issue of a new publication series Cocaine cultivation and production of cocaine is concentrated in Latin America, especially Colombia. providing a much bigger supply of raw material to the cocaine market. The cocaine market continues to be very dynamic and rapidly growing. CRIMJUST is part of the European Unionís Global Illicit Flows Programmed, aiming at fighting international crime, and particularly drug trafficking, through international cooperation and in line with international legal instruments. For its second phase, CRIMJUST has a strong focus on research. It is contributes to the fight against organized crime and drugs trafficking by producing strategic and action-oriented knowledge to support evidence-based policy making and field operations to reduce the cocaine threat.
In 2021 The Narcotic Drugs and Psychotropic Substances (Amendment) Bill, 2021 was passed by Lok Sabha. Two separate pieces of legislations are likely to be piloted to amend the Narcotic Drugs and Psychotropic Substances (NDPS) Act, 1985. The NDPS Act empowers the government to declare any substance as a 'controlled substance' after considering its possible use in the production or manufacture of narcotic drugs or psychotropic substances. Besides the move to decriminalize personal consumption of small quantities of drugs, narcotics and psychotropic substances, the amendments may bring strict punishing provisions against drug traffickers. The Narcotics Control Bureau has however sought clarity on agencies and departments which will be responsible for rehabilitation and deaddiction programmed.

Market Drivers
  • Rising Frequency of Chronic Pain in Adults
  • Demand for Strong Agonists
  • Addiction of Drugs Is Increasing
  • Rising Population of Narcotic Drugs Takers

Opportunities
  • Globally, Millions of People Have Been Suffering from Acute or Chronic Pain

Restraints
  • Difficulty and Risk Related to Use of Product
  • Increasing Cases of Narcotic Drugs Addictions and Overdoses
  • Legal Aspect About Product
  • Habits of Consumers Toward Product

Challenges
  • Difficulties in Controlling Its Use
  • Supply Chain or Even the Different Global Commercial Practices


Key Target Audience
HospitaL, Clinic, Patient, Vendor, Government bodies, Corporate bodies and Others

About Approach
To evaluate and validate the market size various sources including primary and secondary analysis is utilized. AMA Research follows regulatory standards such as NAICS/SIC/ICB/TRCB, to have the better understanding of the market. The market study is conducted on basis of more than 200 companies dealing in the market regional as well as global areas with purpose to understand company’s positioning regarding market value, volume and their market share for regional as well as global.

Further to bring relevance specific to any niche market we set and apply number of criteria like Geographic Footprints, Regional Segments of Revenue, Operational Centres, etc. The next step is to finalize a team (In-House + Data Agencies) who then starts collecting C & D level executives and profiles, Industry experts, Opinion leaders etc. and work towards appointment generation.

The primary research is performed by taking the interviews of executives of various companies dealing in the market as well as using the survey reports, research institute, and latest research reports. Meanwhile, analyst team keeps preparing set of questionnaires and after getting appointee list; the target audience are then tapped and segregated with various mediums and channels that are feasible for making connection that includes email communication, telephonic, skype, LinkedIn Group & InMail, Community Forums, Community Forums, open Survey, SurveyMonkey etc.

Frequently Asked Questions (FAQ):

What all players are profiled in the study?
The standard version of the report profiles players such as Johnson & Johnson (United States), Roche (Switzerland), Novartis Ag (Switzerland), Merck & Co. (United States), Pfizer (United States), Merck (United States), Glaxosmithkline (United Kingdom), Sanofi (Paris), Sun Pharma (India) and Glaxosmithkline Australia Pty Ltd. (Australia) etc.

Can we have customized study for Narcotic Drugs Market?
The Study can be customized subject to feasibility and data availability. Please connect with our sales representative for further information.

Why are some of the most well-known companies left out of the Narcotic Drugs Market report?
The Narcotic Drugs market study includes a random mix of players, including both market leaders and some top growing emerging players. Connect with our sales executive to get a complete company list in our research coverage.

Report Objectives / Segmentation Covered
By Type
  • Opium
  • Heroin
  • Demerol
  • Darvon
  • Others
By Types
  • Stimulants (E.G. Cocaine)
  • Depressants (E.G. Alcohol)
  • Opium-Related Painkillers (E.G. Heroin)
  • Hallucinogens (E.G. Lsd)

By Distribution Channel
  • Offline
  • Online
  • Direct Consumer Sell

By End-user
  • Male
  • Female

By Material
  • Morphine
  • Codeine

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Rising Frequency of Chronic Pain in Adults
      • 3.2.2. Demand for Strong Agonists
      • 3.2.3. Addiction of Drugs Is Increasing
      • 3.2.4. Rising Population of Narcotic Drugs Takers
    • 3.3. Market Challenges
      • 3.3.1. Difficulties in Controlling Its Use
      • 3.3.2. Supply Chain or Even the Different Global Commercial Practices
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Narcotic Drugs, by Type, Types, Distribution Channel, End-user, Material and Region (value, volume and price ) (2016-2021)
    • 5.1. Introduction
    • 5.2. Global Narcotic Drugs (Value)
      • 5.2.1. Global Narcotic Drugs by: Type (Value)
        • 5.2.1.1. Opium
        • 5.2.1.2. Heroin
        • 5.2.1.3. Demerol
        • 5.2.1.4. Darvon
        • 5.2.1.5. Others
      • 5.2.2. Global Narcotic Drugs by: Types (Value)
        • 5.2.2.1. Stimulants (E.G. Cocaine)
        • 5.2.2.2. Depressants (E.G. Alcohol)
        • 5.2.2.3. Opium-Related Painkillers (E.G. Heroin)
        • 5.2.2.4. Hallucinogens (E.G. Lsd)
      • 5.2.3. Global Narcotic Drugs by: Distribution Channel (Value)
        • 5.2.3.1. Offline
        • 5.2.3.2. Online
        • 5.2.3.3. Direct Consumer Sell
      • 5.2.4. Global Narcotic Drugs by: End-user (Value)
        • 5.2.4.1. Male
        • 5.2.4.2. Female
      • 5.2.5. Global Narcotic Drugs by: Material (Value)
        • 5.2.5.1. Morphine
        • 5.2.5.2. Codeine
      • 5.2.6. Global Narcotic Drugs Region
        • 5.2.6.1. South America
          • 5.2.6.1.1. Brazil
          • 5.2.6.1.2. Argentina
          • 5.2.6.1.3. Rest of South America
        • 5.2.6.2. Asia Pacific
          • 5.2.6.2.1. China
          • 5.2.6.2.2. Japan
          • 5.2.6.2.3. India
          • 5.2.6.2.4. South Korea
          • 5.2.6.2.5. Taiwan
          • 5.2.6.2.6. Australia
          • 5.2.6.2.7. Rest of Asia-Pacific
        • 5.2.6.3. Europe
          • 5.2.6.3.1. Germany
          • 5.2.6.3.2. France
          • 5.2.6.3.3. Italy
          • 5.2.6.3.4. United Kingdom
          • 5.2.6.3.5. Netherlands
          • 5.2.6.3.6. Rest of Europe
        • 5.2.6.4. MEA
          • 5.2.6.4.1. Middle East
          • 5.2.6.4.2. Africa
        • 5.2.6.5. North America
          • 5.2.6.5.1. United States
          • 5.2.6.5.2. Canada
          • 5.2.6.5.3. Mexico
    • 5.3. Global Narcotic Drugs (Volume)
      • 5.3.1. Global Narcotic Drugs by: Type (Volume)
        • 5.3.1.1. Opium
        • 5.3.1.2. Heroin
        • 5.3.1.3. Demerol
        • 5.3.1.4. Darvon
        • 5.3.1.5. Others
      • 5.3.2. Global Narcotic Drugs by: Types (Volume)
        • 5.3.2.1. Stimulants (E.G. Cocaine)
        • 5.3.2.2. Depressants (E.G. Alcohol)
        • 5.3.2.3. Opium-Related Painkillers (E.G. Heroin)
        • 5.3.2.4. Hallucinogens (E.G. Lsd)
      • 5.3.3. Global Narcotic Drugs by: Distribution Channel (Volume)
        • 5.3.3.1. Offline
        • 5.3.3.2. Online
        • 5.3.3.3. Direct Consumer Sell
      • 5.3.4. Global Narcotic Drugs by: End-user (Volume)
        • 5.3.4.1. Male
        • 5.3.4.2. Female
      • 5.3.5. Global Narcotic Drugs by: Material (Volume)
        • 5.3.5.1. Morphine
        • 5.3.5.2. Codeine
      • 5.3.6. Global Narcotic Drugs Region
        • 5.3.6.1. South America
          • 5.3.6.1.1. Brazil
          • 5.3.6.1.2. Argentina
          • 5.3.6.1.3. Rest of South America
        • 5.3.6.2. Asia Pacific
          • 5.3.6.2.1. China
          • 5.3.6.2.2. Japan
          • 5.3.6.2.3. India
          • 5.3.6.2.4. South Korea
          • 5.3.6.2.5. Taiwan
          • 5.3.6.2.6. Australia
          • 5.3.6.2.7. Rest of Asia-Pacific
        • 5.3.6.3. Europe
          • 5.3.6.3.1. Germany
          • 5.3.6.3.2. France
          • 5.3.6.3.3. Italy
          • 5.3.6.3.4. United Kingdom
          • 5.3.6.3.5. Netherlands
          • 5.3.6.3.6. Rest of Europe
        • 5.3.6.4. MEA
          • 5.3.6.4.1. Middle East
          • 5.3.6.4.2. Africa
        • 5.3.6.5. North America
          • 5.3.6.5.1. United States
          • 5.3.6.5.2. Canada
          • 5.3.6.5.3. Mexico
    • 5.4. Global Narcotic Drugs (Price)
      • 5.4.1. Global Narcotic Drugs by: Type (Price)
  • 6. Narcotic Drugs: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2021)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. Johnson & Johnson (United States)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. Roche (Switzerland)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. Novartis Ag (Switzerland)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. Merck & Co. (United States)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. Pfizer (United States)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. Merck (United States)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. Glaxosmithkline (United Kingdom)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. Sanofi (Paris)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. Sun Pharma (India)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
      • 6.4.10. Glaxosmithkline Australia Pty Ltd. (Australia)
        • 6.4.10.1. Business Overview
        • 6.4.10.2. Products/Services Offerings
        • 6.4.10.3. Financial Analysis
        • 6.4.10.4. SWOT Analysis
  • 7. Global Narcotic Drugs Sale, by Type, Types, Distribution Channel, End-user, Material and Region (value, volume and price ) (2022-2027)
    • 7.1. Introduction
    • 7.2. Global Narcotic Drugs (Value)
      • 7.2.1. Global Narcotic Drugs by: Type (Value)
        • 7.2.1.1. Opium
        • 7.2.1.2. Heroin
        • 7.2.1.3. Demerol
        • 7.2.1.4. Darvon
        • 7.2.1.5. Others
      • 7.2.2. Global Narcotic Drugs by: Types (Value)
        • 7.2.2.1. Stimulants (E.G. Cocaine)
        • 7.2.2.2. Depressants (E.G. Alcohol)
        • 7.2.2.3. Opium-Related Painkillers (E.G. Heroin)
        • 7.2.2.4. Hallucinogens (E.G. Lsd)
      • 7.2.3. Global Narcotic Drugs by: Distribution Channel (Value)
        • 7.2.3.1. Offline
        • 7.2.3.2. Online
        • 7.2.3.3. Direct Consumer Sell
      • 7.2.4. Global Narcotic Drugs by: End-user (Value)
        • 7.2.4.1. Male
        • 7.2.4.2. Female
      • 7.2.5. Global Narcotic Drugs by: Material (Value)
        • 7.2.5.1. Morphine
        • 7.2.5.2. Codeine
      • 7.2.6. Global Narcotic Drugs Region
        • 7.2.6.1. South America
          • 7.2.6.1.1. Brazil
          • 7.2.6.1.2. Argentina
          • 7.2.6.1.3. Rest of South America
        • 7.2.6.2. Asia Pacific
          • 7.2.6.2.1. China
          • 7.2.6.2.2. Japan
          • 7.2.6.2.3. India
          • 7.2.6.2.4. South Korea
          • 7.2.6.2.5. Taiwan
          • 7.2.6.2.6. Australia
          • 7.2.6.2.7. Rest of Asia-Pacific
        • 7.2.6.3. Europe
          • 7.2.6.3.1. Germany
          • 7.2.6.3.2. France
          • 7.2.6.3.3. Italy
          • 7.2.6.3.4. United Kingdom
          • 7.2.6.3.5. Netherlands
          • 7.2.6.3.6. Rest of Europe
        • 7.2.6.4. MEA
          • 7.2.6.4.1. Middle East
          • 7.2.6.4.2. Africa
        • 7.2.6.5. North America
          • 7.2.6.5.1. United States
          • 7.2.6.5.2. Canada
          • 7.2.6.5.3. Mexico
    • 7.3. Global Narcotic Drugs (Volume)
      • 7.3.1. Global Narcotic Drugs by: Type (Volume)
        • 7.3.1.1. Opium
        • 7.3.1.2. Heroin
        • 7.3.1.3. Demerol
        • 7.3.1.4. Darvon
        • 7.3.1.5. Others
      • 7.3.2. Global Narcotic Drugs by: Types (Volume)
        • 7.3.2.1. Stimulants (E.G. Cocaine)
        • 7.3.2.2. Depressants (E.G. Alcohol)
        • 7.3.2.3. Opium-Related Painkillers (E.G. Heroin)
        • 7.3.2.4. Hallucinogens (E.G. Lsd)
      • 7.3.3. Global Narcotic Drugs by: Distribution Channel (Volume)
        • 7.3.3.1. Offline
        • 7.3.3.2. Online
        • 7.3.3.3. Direct Consumer Sell
      • 7.3.4. Global Narcotic Drugs by: End-user (Volume)
        • 7.3.4.1. Male
        • 7.3.4.2. Female
      • 7.3.5. Global Narcotic Drugs by: Material (Volume)
        • 7.3.5.1. Morphine
        • 7.3.5.2. Codeine
      • 7.3.6. Global Narcotic Drugs Region
        • 7.3.6.1. South America
          • 7.3.6.1.1. Brazil
          • 7.3.6.1.2. Argentina
          • 7.3.6.1.3. Rest of South America
        • 7.3.6.2. Asia Pacific
          • 7.3.6.2.1. China
          • 7.3.6.2.2. Japan
          • 7.3.6.2.3. India
          • 7.3.6.2.4. South Korea
          • 7.3.6.2.5. Taiwan
          • 7.3.6.2.6. Australia
          • 7.3.6.2.7. Rest of Asia-Pacific
        • 7.3.6.3. Europe
          • 7.3.6.3.1. Germany
          • 7.3.6.3.2. France
          • 7.3.6.3.3. Italy
          • 7.3.6.3.4. United Kingdom
          • 7.3.6.3.5. Netherlands
          • 7.3.6.3.6. Rest of Europe
        • 7.3.6.4. MEA
          • 7.3.6.4.1. Middle East
          • 7.3.6.4.2. Africa
        • 7.3.6.5. North America
          • 7.3.6.5.1. United States
          • 7.3.6.5.2. Canada
          • 7.3.6.5.3. Mexico
    • 7.4. Global Narcotic Drugs (Price)
      • 7.4.1. Global Narcotic Drugs by: Type (Price)
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Narcotic Drugs: by Type(USD Million)
  • Table 2. Narcotic Drugs Opium , by Region USD Million (2016-2021)
  • Table 3. Narcotic Drugs Heroin , by Region USD Million (2016-2021)
  • Table 4. Narcotic Drugs Demerol , by Region USD Million (2016-2021)
  • Table 5. Narcotic Drugs Darvon , by Region USD Million (2016-2021)
  • Table 6. Narcotic Drugs Others , by Region USD Million (2016-2021)
  • Table 7. Narcotic Drugs: by Types(USD Million)
  • Table 8. Narcotic Drugs Stimulants (E.G. Cocaine) , by Region USD Million (2016-2021)
  • Table 9. Narcotic Drugs Depressants (E.G. Alcohol) , by Region USD Million (2016-2021)
  • Table 10. Narcotic Drugs Opium-Related Painkillers (E.G. Heroin) , by Region USD Million (2016-2021)
  • Table 11. Narcotic Drugs Hallucinogens (E.G. Lsd) , by Region USD Million (2016-2021)
  • Table 12. Narcotic Drugs: by Distribution Channel(USD Million)
  • Table 13. Narcotic Drugs Offline , by Region USD Million (2016-2021)
  • Table 14. Narcotic Drugs Online , by Region USD Million (2016-2021)
  • Table 15. Narcotic Drugs Direct Consumer Sell , by Region USD Million (2016-2021)
  • Table 16. Narcotic Drugs: by End-user(USD Million)
  • Table 17. Narcotic Drugs Male , by Region USD Million (2016-2021)
  • Table 18. Narcotic Drugs Female , by Region USD Million (2016-2021)
  • Table 19. Narcotic Drugs: by Material(USD Million)
  • Table 20. Narcotic Drugs Morphine , by Region USD Million (2016-2021)
  • Table 21. Narcotic Drugs Codeine , by Region USD Million (2016-2021)
  • Table 22. South America Narcotic Drugs, by Country USD Million (2016-2021)
  • Table 23. South America Narcotic Drugs, by Type USD Million (2016-2021)
  • Table 24. South America Narcotic Drugs, by Types USD Million (2016-2021)
  • Table 25. South America Narcotic Drugs, by Distribution Channel USD Million (2016-2021)
  • Table 26. South America Narcotic Drugs, by End-user USD Million (2016-2021)
  • Table 27. South America Narcotic Drugs, by Material USD Million (2016-2021)
  • Table 28. Brazil Narcotic Drugs, by Type USD Million (2016-2021)
  • Table 29. Brazil Narcotic Drugs, by Types USD Million (2016-2021)
  • Table 30. Brazil Narcotic Drugs, by Distribution Channel USD Million (2016-2021)
  • Table 31. Brazil Narcotic Drugs, by End-user USD Million (2016-2021)
  • Table 32. Brazil Narcotic Drugs, by Material USD Million (2016-2021)
  • Table 33. Argentina Narcotic Drugs, by Type USD Million (2016-2021)
  • Table 34. Argentina Narcotic Drugs, by Types USD Million (2016-2021)
  • Table 35. Argentina Narcotic Drugs, by Distribution Channel USD Million (2016-2021)
  • Table 36. Argentina Narcotic Drugs, by End-user USD Million (2016-2021)
  • Table 37. Argentina Narcotic Drugs, by Material USD Million (2016-2021)
  • Table 38. Rest of South America Narcotic Drugs, by Type USD Million (2016-2021)
  • Table 39. Rest of South America Narcotic Drugs, by Types USD Million (2016-2021)
  • Table 40. Rest of South America Narcotic Drugs, by Distribution Channel USD Million (2016-2021)
  • Table 41. Rest of South America Narcotic Drugs, by End-user USD Million (2016-2021)
  • Table 42. Rest of South America Narcotic Drugs, by Material USD Million (2016-2021)
  • Table 43. Asia Pacific Narcotic Drugs, by Country USD Million (2016-2021)
  • Table 44. Asia Pacific Narcotic Drugs, by Type USD Million (2016-2021)
  • Table 45. Asia Pacific Narcotic Drugs, by Types USD Million (2016-2021)
  • Table 46. Asia Pacific Narcotic Drugs, by Distribution Channel USD Million (2016-2021)
  • Table 47. Asia Pacific Narcotic Drugs, by End-user USD Million (2016-2021)
  • Table 48. Asia Pacific Narcotic Drugs, by Material USD Million (2016-2021)
  • Table 49. China Narcotic Drugs, by Type USD Million (2016-2021)
  • Table 50. China Narcotic Drugs, by Types USD Million (2016-2021)
  • Table 51. China Narcotic Drugs, by Distribution Channel USD Million (2016-2021)
  • Table 52. China Narcotic Drugs, by End-user USD Million (2016-2021)
  • Table 53. China Narcotic Drugs, by Material USD Million (2016-2021)
  • Table 54. Japan Narcotic Drugs, by Type USD Million (2016-2021)
  • Table 55. Japan Narcotic Drugs, by Types USD Million (2016-2021)
  • Table 56. Japan Narcotic Drugs, by Distribution Channel USD Million (2016-2021)
  • Table 57. Japan Narcotic Drugs, by End-user USD Million (2016-2021)
  • Table 58. Japan Narcotic Drugs, by Material USD Million (2016-2021)
  • Table 59. India Narcotic Drugs, by Type USD Million (2016-2021)
  • Table 60. India Narcotic Drugs, by Types USD Million (2016-2021)
  • Table 61. India Narcotic Drugs, by Distribution Channel USD Million (2016-2021)
  • Table 62. India Narcotic Drugs, by End-user USD Million (2016-2021)
  • Table 63. India Narcotic Drugs, by Material USD Million (2016-2021)
  • Table 64. South Korea Narcotic Drugs, by Type USD Million (2016-2021)
  • Table 65. South Korea Narcotic Drugs, by Types USD Million (2016-2021)
  • Table 66. South Korea Narcotic Drugs, by Distribution Channel USD Million (2016-2021)
  • Table 67. South Korea Narcotic Drugs, by End-user USD Million (2016-2021)
  • Table 68. South Korea Narcotic Drugs, by Material USD Million (2016-2021)
  • Table 69. Taiwan Narcotic Drugs, by Type USD Million (2016-2021)
  • Table 70. Taiwan Narcotic Drugs, by Types USD Million (2016-2021)
  • Table 71. Taiwan Narcotic Drugs, by Distribution Channel USD Million (2016-2021)
  • Table 72. Taiwan Narcotic Drugs, by End-user USD Million (2016-2021)
  • Table 73. Taiwan Narcotic Drugs, by Material USD Million (2016-2021)
  • Table 74. Australia Narcotic Drugs, by Type USD Million (2016-2021)
  • Table 75. Australia Narcotic Drugs, by Types USD Million (2016-2021)
  • Table 76. Australia Narcotic Drugs, by Distribution Channel USD Million (2016-2021)
  • Table 77. Australia Narcotic Drugs, by End-user USD Million (2016-2021)
  • Table 78. Australia Narcotic Drugs, by Material USD Million (2016-2021)
  • Table 79. Rest of Asia-Pacific Narcotic Drugs, by Type USD Million (2016-2021)
  • Table 80. Rest of Asia-Pacific Narcotic Drugs, by Types USD Million (2016-2021)
  • Table 81. Rest of Asia-Pacific Narcotic Drugs, by Distribution Channel USD Million (2016-2021)
  • Table 82. Rest of Asia-Pacific Narcotic Drugs, by End-user USD Million (2016-2021)
  • Table 83. Rest of Asia-Pacific Narcotic Drugs, by Material USD Million (2016-2021)
  • Table 84. Europe Narcotic Drugs, by Country USD Million (2016-2021)
  • Table 85. Europe Narcotic Drugs, by Type USD Million (2016-2021)
  • Table 86. Europe Narcotic Drugs, by Types USD Million (2016-2021)
  • Table 87. Europe Narcotic Drugs, by Distribution Channel USD Million (2016-2021)
  • Table 88. Europe Narcotic Drugs, by End-user USD Million (2016-2021)
  • Table 89. Europe Narcotic Drugs, by Material USD Million (2016-2021)
  • Table 90. Germany Narcotic Drugs, by Type USD Million (2016-2021)
  • Table 91. Germany Narcotic Drugs, by Types USD Million (2016-2021)
  • Table 92. Germany Narcotic Drugs, by Distribution Channel USD Million (2016-2021)
  • Table 93. Germany Narcotic Drugs, by End-user USD Million (2016-2021)
  • Table 94. Germany Narcotic Drugs, by Material USD Million (2016-2021)
  • Table 95. France Narcotic Drugs, by Type USD Million (2016-2021)
  • Table 96. France Narcotic Drugs, by Types USD Million (2016-2021)
  • Table 97. France Narcotic Drugs, by Distribution Channel USD Million (2016-2021)
  • Table 98. France Narcotic Drugs, by End-user USD Million (2016-2021)
  • Table 99. France Narcotic Drugs, by Material USD Million (2016-2021)
  • Table 100. Italy Narcotic Drugs, by Type USD Million (2016-2021)
  • Table 101. Italy Narcotic Drugs, by Types USD Million (2016-2021)
  • Table 102. Italy Narcotic Drugs, by Distribution Channel USD Million (2016-2021)
  • Table 103. Italy Narcotic Drugs, by End-user USD Million (2016-2021)
  • Table 104. Italy Narcotic Drugs, by Material USD Million (2016-2021)
  • Table 105. United Kingdom Narcotic Drugs, by Type USD Million (2016-2021)
  • Table 106. United Kingdom Narcotic Drugs, by Types USD Million (2016-2021)
  • Table 107. United Kingdom Narcotic Drugs, by Distribution Channel USD Million (2016-2021)
  • Table 108. United Kingdom Narcotic Drugs, by End-user USD Million (2016-2021)
  • Table 109. United Kingdom Narcotic Drugs, by Material USD Million (2016-2021)
  • Table 110. Netherlands Narcotic Drugs, by Type USD Million (2016-2021)
  • Table 111. Netherlands Narcotic Drugs, by Types USD Million (2016-2021)
  • Table 112. Netherlands Narcotic Drugs, by Distribution Channel USD Million (2016-2021)
  • Table 113. Netherlands Narcotic Drugs, by End-user USD Million (2016-2021)
  • Table 114. Netherlands Narcotic Drugs, by Material USD Million (2016-2021)
  • Table 115. Rest of Europe Narcotic Drugs, by Type USD Million (2016-2021)
  • Table 116. Rest of Europe Narcotic Drugs, by Types USD Million (2016-2021)
  • Table 117. Rest of Europe Narcotic Drugs, by Distribution Channel USD Million (2016-2021)
  • Table 118. Rest of Europe Narcotic Drugs, by End-user USD Million (2016-2021)
  • Table 119. Rest of Europe Narcotic Drugs, by Material USD Million (2016-2021)
  • Table 120. MEA Narcotic Drugs, by Country USD Million (2016-2021)
  • Table 121. MEA Narcotic Drugs, by Type USD Million (2016-2021)
  • Table 122. MEA Narcotic Drugs, by Types USD Million (2016-2021)
  • Table 123. MEA Narcotic Drugs, by Distribution Channel USD Million (2016-2021)
  • Table 124. MEA Narcotic Drugs, by End-user USD Million (2016-2021)
  • Table 125. MEA Narcotic Drugs, by Material USD Million (2016-2021)
  • Table 126. Middle East Narcotic Drugs, by Type USD Million (2016-2021)
  • Table 127. Middle East Narcotic Drugs, by Types USD Million (2016-2021)
  • Table 128. Middle East Narcotic Drugs, by Distribution Channel USD Million (2016-2021)
  • Table 129. Middle East Narcotic Drugs, by End-user USD Million (2016-2021)
  • Table 130. Middle East Narcotic Drugs, by Material USD Million (2016-2021)
  • Table 131. Africa Narcotic Drugs, by Type USD Million (2016-2021)
  • Table 132. Africa Narcotic Drugs, by Types USD Million (2016-2021)
  • Table 133. Africa Narcotic Drugs, by Distribution Channel USD Million (2016-2021)
  • Table 134. Africa Narcotic Drugs, by End-user USD Million (2016-2021)
  • Table 135. Africa Narcotic Drugs, by Material USD Million (2016-2021)
  • Table 136. North America Narcotic Drugs, by Country USD Million (2016-2021)
  • Table 137. North America Narcotic Drugs, by Type USD Million (2016-2021)
  • Table 138. North America Narcotic Drugs, by Types USD Million (2016-2021)
  • Table 139. North America Narcotic Drugs, by Distribution Channel USD Million (2016-2021)
  • Table 140. North America Narcotic Drugs, by End-user USD Million (2016-2021)
  • Table 141. North America Narcotic Drugs, by Material USD Million (2016-2021)
  • Table 142. United States Narcotic Drugs, by Type USD Million (2016-2021)
  • Table 143. United States Narcotic Drugs, by Types USD Million (2016-2021)
  • Table 144. United States Narcotic Drugs, by Distribution Channel USD Million (2016-2021)
  • Table 145. United States Narcotic Drugs, by End-user USD Million (2016-2021)
  • Table 146. United States Narcotic Drugs, by Material USD Million (2016-2021)
  • Table 147. Canada Narcotic Drugs, by Type USD Million (2016-2021)
  • Table 148. Canada Narcotic Drugs, by Types USD Million (2016-2021)
  • Table 149. Canada Narcotic Drugs, by Distribution Channel USD Million (2016-2021)
  • Table 150. Canada Narcotic Drugs, by End-user USD Million (2016-2021)
  • Table 151. Canada Narcotic Drugs, by Material USD Million (2016-2021)
  • Table 152. Mexico Narcotic Drugs, by Type USD Million (2016-2021)
  • Table 153. Mexico Narcotic Drugs, by Types USD Million (2016-2021)
  • Table 154. Mexico Narcotic Drugs, by Distribution Channel USD Million (2016-2021)
  • Table 155. Mexico Narcotic Drugs, by End-user USD Million (2016-2021)
  • Table 156. Mexico Narcotic Drugs, by Material USD Million (2016-2021)
  • Table 157. Narcotic Drugs Sales: by Type(N)
  • Table 158. Narcotic Drugs Sales Opium , by Region N (2016-2021)
  • Table 159. Narcotic Drugs Sales Heroin , by Region N (2016-2021)
  • Table 160. Narcotic Drugs Sales Demerol , by Region N (2016-2021)
  • Table 161. Narcotic Drugs Sales Darvon , by Region N (2016-2021)
  • Table 162. Narcotic Drugs Sales Others , by Region N (2016-2021)
  • Table 163. Narcotic Drugs Sales: by Types(N)
  • Table 164. Narcotic Drugs Sales Stimulants (E.G. Cocaine) , by Region N (2016-2021)
  • Table 165. Narcotic Drugs Sales Depressants (E.G. Alcohol) , by Region N (2016-2021)
  • Table 166. Narcotic Drugs Sales Opium-Related Painkillers (E.G. Heroin) , by Region N (2016-2021)
  • Table 167. Narcotic Drugs Sales Hallucinogens (E.G. Lsd) , by Region N (2016-2021)
  • Table 168. Narcotic Drugs Sales: by Distribution Channel(N)
  • Table 169. Narcotic Drugs Sales Offline , by Region N (2016-2021)
  • Table 170. Narcotic Drugs Sales Online , by Region N (2016-2021)
  • Table 171. Narcotic Drugs Sales Direct Consumer Sell , by Region N (2016-2021)
  • Table 172. Narcotic Drugs Sales: by End-user(N)
  • Table 173. Narcotic Drugs Sales Male , by Region N (2016-2021)
  • Table 174. Narcotic Drugs Sales Female , by Region N (2016-2021)
  • Table 175. Narcotic Drugs Sales: by Material(N)
  • Table 176. Narcotic Drugs Sales Morphine , by Region N (2016-2021)
  • Table 177. Narcotic Drugs Sales Codeine , by Region N (2016-2021)
  • Table 178. South America Narcotic Drugs Sales, by Country N (2016-2021)
  • Table 179. South America Narcotic Drugs Sales, by Type N (2016-2021)
  • Table 180. South America Narcotic Drugs Sales, by Types N (2016-2021)
  • Table 181. South America Narcotic Drugs Sales, by Distribution Channel N (2016-2021)
  • Table 182. South America Narcotic Drugs Sales, by End-user N (2016-2021)
  • Table 183. South America Narcotic Drugs Sales, by Material N (2016-2021)
  • Table 184. Brazil Narcotic Drugs Sales, by Type N (2016-2021)
  • Table 185. Brazil Narcotic Drugs Sales, by Types N (2016-2021)
  • Table 186. Brazil Narcotic Drugs Sales, by Distribution Channel N (2016-2021)
  • Table 187. Brazil Narcotic Drugs Sales, by End-user N (2016-2021)
  • Table 188. Brazil Narcotic Drugs Sales, by Material N (2016-2021)
  • Table 189. Argentina Narcotic Drugs Sales, by Type N (2016-2021)
  • Table 190. Argentina Narcotic Drugs Sales, by Types N (2016-2021)
  • Table 191. Argentina Narcotic Drugs Sales, by Distribution Channel N (2016-2021)
  • Table 192. Argentina Narcotic Drugs Sales, by End-user N (2016-2021)
  • Table 193. Argentina Narcotic Drugs Sales, by Material N (2016-2021)
  • Table 194. Rest of South America Narcotic Drugs Sales, by Type N (2016-2021)
  • Table 195. Rest of South America Narcotic Drugs Sales, by Types N (2016-2021)
  • Table 196. Rest of South America Narcotic Drugs Sales, by Distribution Channel N (2016-2021)
  • Table 197. Rest of South America Narcotic Drugs Sales, by End-user N (2016-2021)
  • Table 198. Rest of South America Narcotic Drugs Sales, by Material N (2016-2021)
  • Table 199. Asia Pacific Narcotic Drugs Sales, by Country N (2016-2021)
  • Table 200. Asia Pacific Narcotic Drugs Sales, by Type N (2016-2021)
  • Table 201. Asia Pacific Narcotic Drugs Sales, by Types N (2016-2021)
  • Table 202. Asia Pacific Narcotic Drugs Sales, by Distribution Channel N (2016-2021)
  • Table 203. Asia Pacific Narcotic Drugs Sales, by End-user N (2016-2021)
  • Table 204. Asia Pacific Narcotic Drugs Sales, by Material N (2016-2021)
  • Table 205. China Narcotic Drugs Sales, by Type N (2016-2021)
  • Table 206. China Narcotic Drugs Sales, by Types N (2016-2021)
  • Table 207. China Narcotic Drugs Sales, by Distribution Channel N (2016-2021)
  • Table 208. China Narcotic Drugs Sales, by End-user N (2016-2021)
  • Table 209. China Narcotic Drugs Sales, by Material N (2016-2021)
  • Table 210. Japan Narcotic Drugs Sales, by Type N (2016-2021)
  • Table 211. Japan Narcotic Drugs Sales, by Types N (2016-2021)
  • Table 212. Japan Narcotic Drugs Sales, by Distribution Channel N (2016-2021)
  • Table 213. Japan Narcotic Drugs Sales, by End-user N (2016-2021)
  • Table 214. Japan Narcotic Drugs Sales, by Material N (2016-2021)
  • Table 215. India Narcotic Drugs Sales, by Type N (2016-2021)
  • Table 216. India Narcotic Drugs Sales, by Types N (2016-2021)
  • Table 217. India Narcotic Drugs Sales, by Distribution Channel N (2016-2021)
  • Table 218. India Narcotic Drugs Sales, by End-user N (2016-2021)
  • Table 219. India Narcotic Drugs Sales, by Material N (2016-2021)
  • Table 220. South Korea Narcotic Drugs Sales, by Type N (2016-2021)
  • Table 221. South Korea Narcotic Drugs Sales, by Types N (2016-2021)
  • Table 222. South Korea Narcotic Drugs Sales, by Distribution Channel N (2016-2021)
  • Table 223. South Korea Narcotic Drugs Sales, by End-user N (2016-2021)
  • Table 224. South Korea Narcotic Drugs Sales, by Material N (2016-2021)
  • Table 225. Taiwan Narcotic Drugs Sales, by Type N (2016-2021)
  • Table 226. Taiwan Narcotic Drugs Sales, by Types N (2016-2021)
  • Table 227. Taiwan Narcotic Drugs Sales, by Distribution Channel N (2016-2021)
  • Table 228. Taiwan Narcotic Drugs Sales, by End-user N (2016-2021)
  • Table 229. Taiwan Narcotic Drugs Sales, by Material N (2016-2021)
  • Table 230. Australia Narcotic Drugs Sales, by Type N (2016-2021)
  • Table 231. Australia Narcotic Drugs Sales, by Types N (2016-2021)
  • Table 232. Australia Narcotic Drugs Sales, by Distribution Channel N (2016-2021)
  • Table 233. Australia Narcotic Drugs Sales, by End-user N (2016-2021)
  • Table 234. Australia Narcotic Drugs Sales, by Material N (2016-2021)
  • Table 235. Rest of Asia-Pacific Narcotic Drugs Sales, by Type N (2016-2021)
  • Table 236. Rest of Asia-Pacific Narcotic Drugs Sales, by Types N (2016-2021)
  • Table 237. Rest of Asia-Pacific Narcotic Drugs Sales, by Distribution Channel N (2016-2021)
  • Table 238. Rest of Asia-Pacific Narcotic Drugs Sales, by End-user N (2016-2021)
  • Table 239. Rest of Asia-Pacific Narcotic Drugs Sales, by Material N (2016-2021)
  • Table 240. Europe Narcotic Drugs Sales, by Country N (2016-2021)
  • Table 241. Europe Narcotic Drugs Sales, by Type N (2016-2021)
  • Table 242. Europe Narcotic Drugs Sales, by Types N (2016-2021)
  • Table 243. Europe Narcotic Drugs Sales, by Distribution Channel N (2016-2021)
  • Table 244. Europe Narcotic Drugs Sales, by End-user N (2016-2021)
  • Table 245. Europe Narcotic Drugs Sales, by Material N (2016-2021)
  • Table 246. Germany Narcotic Drugs Sales, by Type N (2016-2021)
  • Table 247. Germany Narcotic Drugs Sales, by Types N (2016-2021)
  • Table 248. Germany Narcotic Drugs Sales, by Distribution Channel N (2016-2021)
  • Table 249. Germany Narcotic Drugs Sales, by End-user N (2016-2021)
  • Table 250. Germany Narcotic Drugs Sales, by Material N (2016-2021)
  • Table 251. France Narcotic Drugs Sales, by Type N (2016-2021)
  • Table 252. France Narcotic Drugs Sales, by Types N (2016-2021)
  • Table 253. France Narcotic Drugs Sales, by Distribution Channel N (2016-2021)
  • Table 254. France Narcotic Drugs Sales, by End-user N (2016-2021)
  • Table 255. France Narcotic Drugs Sales, by Material N (2016-2021)
  • Table 256. Italy Narcotic Drugs Sales, by Type N (2016-2021)
  • Table 257. Italy Narcotic Drugs Sales, by Types N (2016-2021)
  • Table 258. Italy Narcotic Drugs Sales, by Distribution Channel N (2016-2021)
  • Table 259. Italy Narcotic Drugs Sales, by End-user N (2016-2021)
  • Table 260. Italy Narcotic Drugs Sales, by Material N (2016-2021)
  • Table 261. United Kingdom Narcotic Drugs Sales, by Type N (2016-2021)
  • Table 262. United Kingdom Narcotic Drugs Sales, by Types N (2016-2021)
  • Table 263. United Kingdom Narcotic Drugs Sales, by Distribution Channel N (2016-2021)
  • Table 264. United Kingdom Narcotic Drugs Sales, by End-user N (2016-2021)
  • Table 265. United Kingdom Narcotic Drugs Sales, by Material N (2016-2021)
  • Table 266. Netherlands Narcotic Drugs Sales, by Type N (2016-2021)
  • Table 267. Netherlands Narcotic Drugs Sales, by Types N (2016-2021)
  • Table 268. Netherlands Narcotic Drugs Sales, by Distribution Channel N (2016-2021)
  • Table 269. Netherlands Narcotic Drugs Sales, by End-user N (2016-2021)
  • Table 270. Netherlands Narcotic Drugs Sales, by Material N (2016-2021)
  • Table 271. Rest of Europe Narcotic Drugs Sales, by Type N (2016-2021)
  • Table 272. Rest of Europe Narcotic Drugs Sales, by Types N (2016-2021)
  • Table 273. Rest of Europe Narcotic Drugs Sales, by Distribution Channel N (2016-2021)
  • Table 274. Rest of Europe Narcotic Drugs Sales, by End-user N (2016-2021)
  • Table 275. Rest of Europe Narcotic Drugs Sales, by Material N (2016-2021)
  • Table 276. MEA Narcotic Drugs Sales, by Country N (2016-2021)
  • Table 277. MEA Narcotic Drugs Sales, by Type N (2016-2021)
  • Table 278. MEA Narcotic Drugs Sales, by Types N (2016-2021)
  • Table 279. MEA Narcotic Drugs Sales, by Distribution Channel N (2016-2021)
  • Table 280. MEA Narcotic Drugs Sales, by End-user N (2016-2021)
  • Table 281. MEA Narcotic Drugs Sales, by Material N (2016-2021)
  • Table 282. Middle East Narcotic Drugs Sales, by Type N (2016-2021)
  • Table 283. Middle East Narcotic Drugs Sales, by Types N (2016-2021)
  • Table 284. Middle East Narcotic Drugs Sales, by Distribution Channel N (2016-2021)
  • Table 285. Middle East Narcotic Drugs Sales, by End-user N (2016-2021)
  • Table 286. Middle East Narcotic Drugs Sales, by Material N (2016-2021)
  • Table 287. Africa Narcotic Drugs Sales, by Type N (2016-2021)
  • Table 288. Africa Narcotic Drugs Sales, by Types N (2016-2021)
  • Table 289. Africa Narcotic Drugs Sales, by Distribution Channel N (2016-2021)
  • Table 290. Africa Narcotic Drugs Sales, by End-user N (2016-2021)
  • Table 291. Africa Narcotic Drugs Sales, by Material N (2016-2021)
  • Table 292. North America Narcotic Drugs Sales, by Country N (2016-2021)
  • Table 293. North America Narcotic Drugs Sales, by Type N (2016-2021)
  • Table 294. North America Narcotic Drugs Sales, by Types N (2016-2021)
  • Table 295. North America Narcotic Drugs Sales, by Distribution Channel N (2016-2021)
  • Table 296. North America Narcotic Drugs Sales, by End-user N (2016-2021)
  • Table 297. North America Narcotic Drugs Sales, by Material N (2016-2021)
  • Table 298. United States Narcotic Drugs Sales, by Type N (2016-2021)
  • Table 299. United States Narcotic Drugs Sales, by Types N (2016-2021)
  • Table 300. United States Narcotic Drugs Sales, by Distribution Channel N (2016-2021)
  • Table 301. United States Narcotic Drugs Sales, by End-user N (2016-2021)
  • Table 302. United States Narcotic Drugs Sales, by Material N (2016-2021)
  • Table 303. Canada Narcotic Drugs Sales, by Type N (2016-2021)
  • Table 304. Canada Narcotic Drugs Sales, by Types N (2016-2021)
  • Table 305. Canada Narcotic Drugs Sales, by Distribution Channel N (2016-2021)
  • Table 306. Canada Narcotic Drugs Sales, by End-user N (2016-2021)
  • Table 307. Canada Narcotic Drugs Sales, by Material N (2016-2021)
  • Table 308. Mexico Narcotic Drugs Sales, by Type N (2016-2021)
  • Table 309. Mexico Narcotic Drugs Sales, by Types N (2016-2021)
  • Table 310. Mexico Narcotic Drugs Sales, by Distribution Channel N (2016-2021)
  • Table 311. Mexico Narcotic Drugs Sales, by End-user N (2016-2021)
  • Table 312. Mexico Narcotic Drugs Sales, by Material N (2016-2021)
  • Table 313. Narcotic Drugs: by Type(USD/Units)
  • Table 314. Company Basic Information, Sales Area and Its Competitors
  • Table 315. Company Basic Information, Sales Area and Its Competitors
  • Table 316. Company Basic Information, Sales Area and Its Competitors
  • Table 317. Company Basic Information, Sales Area and Its Competitors
  • Table 318. Company Basic Information, Sales Area and Its Competitors
  • Table 319. Company Basic Information, Sales Area and Its Competitors
  • Table 320. Company Basic Information, Sales Area and Its Competitors
  • Table 321. Company Basic Information, Sales Area and Its Competitors
  • Table 322. Company Basic Information, Sales Area and Its Competitors
  • Table 323. Company Basic Information, Sales Area and Its Competitors
  • Table 324. Narcotic Drugs: by Type(USD Million)
  • Table 325. Narcotic Drugs Opium , by Region USD Million (2022-2027)
  • Table 326. Narcotic Drugs Heroin , by Region USD Million (2022-2027)
  • Table 327. Narcotic Drugs Demerol , by Region USD Million (2022-2027)
  • Table 328. Narcotic Drugs Darvon , by Region USD Million (2022-2027)
  • Table 329. Narcotic Drugs Others , by Region USD Million (2022-2027)
  • Table 330. Narcotic Drugs: by Types(USD Million)
  • Table 331. Narcotic Drugs Stimulants (E.G. Cocaine) , by Region USD Million (2022-2027)
  • Table 332. Narcotic Drugs Depressants (E.G. Alcohol) , by Region USD Million (2022-2027)
  • Table 333. Narcotic Drugs Opium-Related Painkillers (E.G. Heroin) , by Region USD Million (2022-2027)
  • Table 334. Narcotic Drugs Hallucinogens (E.G. Lsd) , by Region USD Million (2022-2027)
  • Table 335. Narcotic Drugs: by Distribution Channel(USD Million)
  • Table 336. Narcotic Drugs Offline , by Region USD Million (2022-2027)
  • Table 337. Narcotic Drugs Online , by Region USD Million (2022-2027)
  • Table 338. Narcotic Drugs Direct Consumer Sell , by Region USD Million (2022-2027)
  • Table 339. Narcotic Drugs: by End-user(USD Million)
  • Table 340. Narcotic Drugs Male , by Region USD Million (2022-2027)
  • Table 341. Narcotic Drugs Female , by Region USD Million (2022-2027)
  • Table 342. Narcotic Drugs: by Material(USD Million)
  • Table 343. Narcotic Drugs Morphine , by Region USD Million (2022-2027)
  • Table 344. Narcotic Drugs Codeine , by Region USD Million (2022-2027)
  • Table 345. South America Narcotic Drugs, by Country USD Million (2022-2027)
  • Table 346. South America Narcotic Drugs, by Type USD Million (2022-2027)
  • Table 347. South America Narcotic Drugs, by Types USD Million (2022-2027)
  • Table 348. South America Narcotic Drugs, by Distribution Channel USD Million (2022-2027)
  • Table 349. South America Narcotic Drugs, by End-user USD Million (2022-2027)
  • Table 350. South America Narcotic Drugs, by Material USD Million (2022-2027)
  • Table 351. Brazil Narcotic Drugs, by Type USD Million (2022-2027)
  • Table 352. Brazil Narcotic Drugs, by Types USD Million (2022-2027)
  • Table 353. Brazil Narcotic Drugs, by Distribution Channel USD Million (2022-2027)
  • Table 354. Brazil Narcotic Drugs, by End-user USD Million (2022-2027)
  • Table 355. Brazil Narcotic Drugs, by Material USD Million (2022-2027)
  • Table 356. Argentina Narcotic Drugs, by Type USD Million (2022-2027)
  • Table 357. Argentina Narcotic Drugs, by Types USD Million (2022-2027)
  • Table 358. Argentina Narcotic Drugs, by Distribution Channel USD Million (2022-2027)
  • Table 359. Argentina Narcotic Drugs, by End-user USD Million (2022-2027)
  • Table 360. Argentina Narcotic Drugs, by Material USD Million (2022-2027)
  • Table 361. Rest of South America Narcotic Drugs, by Type USD Million (2022-2027)
  • Table 362. Rest of South America Narcotic Drugs, by Types USD Million (2022-2027)
  • Table 363. Rest of South America Narcotic Drugs, by Distribution Channel USD Million (2022-2027)
  • Table 364. Rest of South America Narcotic Drugs, by End-user USD Million (2022-2027)
  • Table 365. Rest of South America Narcotic Drugs, by Material USD Million (2022-2027)
  • Table 366. Asia Pacific Narcotic Drugs, by Country USD Million (2022-2027)
  • Table 367. Asia Pacific Narcotic Drugs, by Type USD Million (2022-2027)
  • Table 368. Asia Pacific Narcotic Drugs, by Types USD Million (2022-2027)
  • Table 369. Asia Pacific Narcotic Drugs, by Distribution Channel USD Million (2022-2027)
  • Table 370. Asia Pacific Narcotic Drugs, by End-user USD Million (2022-2027)
  • Table 371. Asia Pacific Narcotic Drugs, by Material USD Million (2022-2027)
  • Table 372. China Narcotic Drugs, by Type USD Million (2022-2027)
  • Table 373. China Narcotic Drugs, by Types USD Million (2022-2027)
  • Table 374. China Narcotic Drugs, by Distribution Channel USD Million (2022-2027)
  • Table 375. China Narcotic Drugs, by End-user USD Million (2022-2027)
  • Table 376. China Narcotic Drugs, by Material USD Million (2022-2027)
  • Table 377. Japan Narcotic Drugs, by Type USD Million (2022-2027)
  • Table 378. Japan Narcotic Drugs, by Types USD Million (2022-2027)
  • Table 379. Japan Narcotic Drugs, by Distribution Channel USD Million (2022-2027)
  • Table 380. Japan Narcotic Drugs, by End-user USD Million (2022-2027)
  • Table 381. Japan Narcotic Drugs, by Material USD Million (2022-2027)
  • Table 382. India Narcotic Drugs, by Type USD Million (2022-2027)
  • Table 383. India Narcotic Drugs, by Types USD Million (2022-2027)
  • Table 384. India Narcotic Drugs, by Distribution Channel USD Million (2022-2027)
  • Table 385. India Narcotic Drugs, by End-user USD Million (2022-2027)
  • Table 386. India Narcotic Drugs, by Material USD Million (2022-2027)
  • Table 387. South Korea Narcotic Drugs, by Type USD Million (2022-2027)
  • Table 388. South Korea Narcotic Drugs, by Types USD Million (2022-2027)
  • Table 389. South Korea Narcotic Drugs, by Distribution Channel USD Million (2022-2027)
  • Table 390. South Korea Narcotic Drugs, by End-user USD Million (2022-2027)
  • Table 391. South Korea Narcotic Drugs, by Material USD Million (2022-2027)
  • Table 392. Taiwan Narcotic Drugs, by Type USD Million (2022-2027)
  • Table 393. Taiwan Narcotic Drugs, by Types USD Million (2022-2027)
  • Table 394. Taiwan Narcotic Drugs, by Distribution Channel USD Million (2022-2027)
  • Table 395. Taiwan Narcotic Drugs, by End-user USD Million (2022-2027)
  • Table 396. Taiwan Narcotic Drugs, by Material USD Million (2022-2027)
  • Table 397. Australia Narcotic Drugs, by Type USD Million (2022-2027)
  • Table 398. Australia Narcotic Drugs, by Types USD Million (2022-2027)
  • Table 399. Australia Narcotic Drugs, by Distribution Channel USD Million (2022-2027)
  • Table 400. Australia Narcotic Drugs, by End-user USD Million (2022-2027)
  • Table 401. Australia Narcotic Drugs, by Material USD Million (2022-2027)
  • Table 402. Rest of Asia-Pacific Narcotic Drugs, by Type USD Million (2022-2027)
  • Table 403. Rest of Asia-Pacific Narcotic Drugs, by Types USD Million (2022-2027)
  • Table 404. Rest of Asia-Pacific Narcotic Drugs, by Distribution Channel USD Million (2022-2027)
  • Table 405. Rest of Asia-Pacific Narcotic Drugs, by End-user USD Million (2022-2027)
  • Table 406. Rest of Asia-Pacific Narcotic Drugs, by Material USD Million (2022-2027)
  • Table 407. Europe Narcotic Drugs, by Country USD Million (2022-2027)
  • Table 408. Europe Narcotic Drugs, by Type USD Million (2022-2027)
  • Table 409. Europe Narcotic Drugs, by Types USD Million (2022-2027)
  • Table 410. Europe Narcotic Drugs, by Distribution Channel USD Million (2022-2027)
  • Table 411. Europe Narcotic Drugs, by End-user USD Million (2022-2027)
  • Table 412. Europe Narcotic Drugs, by Material USD Million (2022-2027)
  • Table 413. Germany Narcotic Drugs, by Type USD Million (2022-2027)
  • Table 414. Germany Narcotic Drugs, by Types USD Million (2022-2027)
  • Table 415. Germany Narcotic Drugs, by Distribution Channel USD Million (2022-2027)
  • Table 416. Germany Narcotic Drugs, by End-user USD Million (2022-2027)
  • Table 417. Germany Narcotic Drugs, by Material USD Million (2022-2027)
  • Table 418. France Narcotic Drugs, by Type USD Million (2022-2027)
  • Table 419. France Narcotic Drugs, by Types USD Million (2022-2027)
  • Table 420. France Narcotic Drugs, by Distribution Channel USD Million (2022-2027)
  • Table 421. France Narcotic Drugs, by End-user USD Million (2022-2027)
  • Table 422. France Narcotic Drugs, by Material USD Million (2022-2027)
  • Table 423. Italy Narcotic Drugs, by Type USD Million (2022-2027)
  • Table 424. Italy Narcotic Drugs, by Types USD Million (2022-2027)
  • Table 425. Italy Narcotic Drugs, by Distribution Channel USD Million (2022-2027)
  • Table 426. Italy Narcotic Drugs, by End-user USD Million (2022-2027)
  • Table 427. Italy Narcotic Drugs, by Material USD Million (2022-2027)
  • Table 428. United Kingdom Narcotic Drugs, by Type USD Million (2022-2027)
  • Table 429. United Kingdom Narcotic Drugs, by Types USD Million (2022-2027)
  • Table 430. United Kingdom Narcotic Drugs, by Distribution Channel USD Million (2022-2027)
  • Table 431. United Kingdom Narcotic Drugs, by End-user USD Million (2022-2027)
  • Table 432. United Kingdom Narcotic Drugs, by Material USD Million (2022-2027)
  • Table 433. Netherlands Narcotic Drugs, by Type USD Million (2022-2027)
  • Table 434. Netherlands Narcotic Drugs, by Types USD Million (2022-2027)
  • Table 435. Netherlands Narcotic Drugs, by Distribution Channel USD Million (2022-2027)
  • Table 436. Netherlands Narcotic Drugs, by End-user USD Million (2022-2027)
  • Table 437. Netherlands Narcotic Drugs, by Material USD Million (2022-2027)
  • Table 438. Rest of Europe Narcotic Drugs, by Type USD Million (2022-2027)
  • Table 439. Rest of Europe Narcotic Drugs, by Types USD Million (2022-2027)
  • Table 440. Rest of Europe Narcotic Drugs, by Distribution Channel USD Million (2022-2027)
  • Table 441. Rest of Europe Narcotic Drugs, by End-user USD Million (2022-2027)
  • Table 442. Rest of Europe Narcotic Drugs, by Material USD Million (2022-2027)
  • Table 443. MEA Narcotic Drugs, by Country USD Million (2022-2027)
  • Table 444. MEA Narcotic Drugs, by Type USD Million (2022-2027)
  • Table 445. MEA Narcotic Drugs, by Types USD Million (2022-2027)
  • Table 446. MEA Narcotic Drugs, by Distribution Channel USD Million (2022-2027)
  • Table 447. MEA Narcotic Drugs, by End-user USD Million (2022-2027)
  • Table 448. MEA Narcotic Drugs, by Material USD Million (2022-2027)
  • Table 449. Middle East Narcotic Drugs, by Type USD Million (2022-2027)
  • Table 450. Middle East Narcotic Drugs, by Types USD Million (2022-2027)
  • Table 451. Middle East Narcotic Drugs, by Distribution Channel USD Million (2022-2027)
  • Table 452. Middle East Narcotic Drugs, by End-user USD Million (2022-2027)
  • Table 453. Middle East Narcotic Drugs, by Material USD Million (2022-2027)
  • Table 454. Africa Narcotic Drugs, by Type USD Million (2022-2027)
  • Table 455. Africa Narcotic Drugs, by Types USD Million (2022-2027)
  • Table 456. Africa Narcotic Drugs, by Distribution Channel USD Million (2022-2027)
  • Table 457. Africa Narcotic Drugs, by End-user USD Million (2022-2027)
  • Table 458. Africa Narcotic Drugs, by Material USD Million (2022-2027)
  • Table 459. North America Narcotic Drugs, by Country USD Million (2022-2027)
  • Table 460. North America Narcotic Drugs, by Type USD Million (2022-2027)
  • Table 461. North America Narcotic Drugs, by Types USD Million (2022-2027)
  • Table 462. North America Narcotic Drugs, by Distribution Channel USD Million (2022-2027)
  • Table 463. North America Narcotic Drugs, by End-user USD Million (2022-2027)
  • Table 464. North America Narcotic Drugs, by Material USD Million (2022-2027)
  • Table 465. United States Narcotic Drugs, by Type USD Million (2022-2027)
  • Table 466. United States Narcotic Drugs, by Types USD Million (2022-2027)
  • Table 467. United States Narcotic Drugs, by Distribution Channel USD Million (2022-2027)
  • Table 468. United States Narcotic Drugs, by End-user USD Million (2022-2027)
  • Table 469. United States Narcotic Drugs, by Material USD Million (2022-2027)
  • Table 470. Canada Narcotic Drugs, by Type USD Million (2022-2027)
  • Table 471. Canada Narcotic Drugs, by Types USD Million (2022-2027)
  • Table 472. Canada Narcotic Drugs, by Distribution Channel USD Million (2022-2027)
  • Table 473. Canada Narcotic Drugs, by End-user USD Million (2022-2027)
  • Table 474. Canada Narcotic Drugs, by Material USD Million (2022-2027)
  • Table 475. Mexico Narcotic Drugs, by Type USD Million (2022-2027)
  • Table 476. Mexico Narcotic Drugs, by Types USD Million (2022-2027)
  • Table 477. Mexico Narcotic Drugs, by Distribution Channel USD Million (2022-2027)
  • Table 478. Mexico Narcotic Drugs, by End-user USD Million (2022-2027)
  • Table 479. Mexico Narcotic Drugs, by Material USD Million (2022-2027)
  • Table 480. Narcotic Drugs Sales: by Type(N)
  • Table 481. Narcotic Drugs Sales Opium , by Region N (2022-2027)
  • Table 482. Narcotic Drugs Sales Heroin , by Region N (2022-2027)
  • Table 483. Narcotic Drugs Sales Demerol , by Region N (2022-2027)
  • Table 484. Narcotic Drugs Sales Darvon , by Region N (2022-2027)
  • Table 485. Narcotic Drugs Sales Others , by Region N (2022-2027)
  • Table 486. Narcotic Drugs Sales: by Types(N)
  • Table 487. Narcotic Drugs Sales Stimulants (E.G. Cocaine) , by Region N (2022-2027)
  • Table 488. Narcotic Drugs Sales Depressants (E.G. Alcohol) , by Region N (2022-2027)
  • Table 489. Narcotic Drugs Sales Opium-Related Painkillers (E.G. Heroin) , by Region N (2022-2027)
  • Table 490. Narcotic Drugs Sales Hallucinogens (E.G. Lsd) , by Region N (2022-2027)
  • Table 491. Narcotic Drugs Sales: by Distribution Channel(N)
  • Table 492. Narcotic Drugs Sales Offline , by Region N (2022-2027)
  • Table 493. Narcotic Drugs Sales Online , by Region N (2022-2027)
  • Table 494. Narcotic Drugs Sales Direct Consumer Sell , by Region N (2022-2027)
  • Table 495. Narcotic Drugs Sales: by End-user(N)
  • Table 496. Narcotic Drugs Sales Male , by Region N (2022-2027)
  • Table 497. Narcotic Drugs Sales Female , by Region N (2022-2027)
  • Table 498. Narcotic Drugs Sales: by Material(N)
  • Table 499. Narcotic Drugs Sales Morphine , by Region N (2022-2027)
  • Table 500. Narcotic Drugs Sales Codeine , by Region N (2022-2027)
  • Table 501. South America Narcotic Drugs Sales, by Country N (2022-2027)
  • Table 502. South America Narcotic Drugs Sales, by Type N (2022-2027)
  • Table 503. South America Narcotic Drugs Sales, by Types N (2022-2027)
  • Table 504. South America Narcotic Drugs Sales, by Distribution Channel N (2022-2027)
  • Table 505. South America Narcotic Drugs Sales, by End-user N (2022-2027)
  • Table 506. South America Narcotic Drugs Sales, by Material N (2022-2027)
  • Table 507. Brazil Narcotic Drugs Sales, by Type N (2022-2027)
  • Table 508. Brazil Narcotic Drugs Sales, by Types N (2022-2027)
  • Table 509. Brazil Narcotic Drugs Sales, by Distribution Channel N (2022-2027)
  • Table 510. Brazil Narcotic Drugs Sales, by End-user N (2022-2027)
  • Table 511. Brazil Narcotic Drugs Sales, by Material N (2022-2027)
  • Table 512. Argentina Narcotic Drugs Sales, by Type N (2022-2027)
  • Table 513. Argentina Narcotic Drugs Sales, by Types N (2022-2027)
  • Table 514. Argentina Narcotic Drugs Sales, by Distribution Channel N (2022-2027)
  • Table 515. Argentina Narcotic Drugs Sales, by End-user N (2022-2027)
  • Table 516. Argentina Narcotic Drugs Sales, by Material N (2022-2027)
  • Table 517. Rest of South America Narcotic Drugs Sales, by Type N (2022-2027)
  • Table 518. Rest of South America Narcotic Drugs Sales, by Types N (2022-2027)
  • Table 519. Rest of South America Narcotic Drugs Sales, by Distribution Channel N (2022-2027)
  • Table 520. Rest of South America Narcotic Drugs Sales, by End-user N (2022-2027)
  • Table 521. Rest of South America Narcotic Drugs Sales, by Material N (2022-2027)
  • Table 522. Asia Pacific Narcotic Drugs Sales, by Country N (2022-2027)
  • Table 523. Asia Pacific Narcotic Drugs Sales, by Type N (2022-2027)
  • Table 524. Asia Pacific Narcotic Drugs Sales, by Types N (2022-2027)
  • Table 525. Asia Pacific Narcotic Drugs Sales, by Distribution Channel N (2022-2027)
  • Table 526. Asia Pacific Narcotic Drugs Sales, by End-user N (2022-2027)
  • Table 527. Asia Pacific Narcotic Drugs Sales, by Material N (2022-2027)
  • Table 528. China Narcotic Drugs Sales, by Type N (2022-2027)
  • Table 529. China Narcotic Drugs Sales, by Types N (2022-2027)
  • Table 530. China Narcotic Drugs Sales, by Distribution Channel N (2022-2027)
  • Table 531. China Narcotic Drugs Sales, by End-user N (2022-2027)
  • Table 532. China Narcotic Drugs Sales, by Material N (2022-2027)
  • Table 533. Japan Narcotic Drugs Sales, by Type N (2022-2027)
  • Table 534. Japan Narcotic Drugs Sales, by Types N (2022-2027)
  • Table 535. Japan Narcotic Drugs Sales, by Distribution Channel N (2022-2027)
  • Table 536. Japan Narcotic Drugs Sales, by End-user N (2022-2027)
  • Table 537. Japan Narcotic Drugs Sales, by Material N (2022-2027)
  • Table 538. India Narcotic Drugs Sales, by Type N (2022-2027)
  • Table 539. India Narcotic Drugs Sales, by Types N (2022-2027)
  • Table 540. India Narcotic Drugs Sales, by Distribution Channel N (2022-2027)
  • Table 541. India Narcotic Drugs Sales, by End-user N (2022-2027)
  • Table 542. India Narcotic Drugs Sales, by Material N (2022-2027)
  • Table 543. South Korea Narcotic Drugs Sales, by Type N (2022-2027)
  • Table 544. South Korea Narcotic Drugs Sales, by Types N (2022-2027)
  • Table 545. South Korea Narcotic Drugs Sales, by Distribution Channel N (2022-2027)
  • Table 546. South Korea Narcotic Drugs Sales, by End-user N (2022-2027)
  • Table 547. South Korea Narcotic Drugs Sales, by Material N (2022-2027)
  • Table 548. Taiwan Narcotic Drugs Sales, by Type N (2022-2027)
  • Table 549. Taiwan Narcotic Drugs Sales, by Types N (2022-2027)
  • Table 550. Taiwan Narcotic Drugs Sales, by Distribution Channel N (2022-2027)
  • Table 551. Taiwan Narcotic Drugs Sales, by End-user N (2022-2027)
  • Table 552. Taiwan Narcotic Drugs Sales, by Material N (2022-2027)
  • Table 553. Australia Narcotic Drugs Sales, by Type N (2022-2027)
  • Table 554. Australia Narcotic Drugs Sales, by Types N (2022-2027)
  • Table 555. Australia Narcotic Drugs Sales, by Distribution Channel N (2022-2027)
  • Table 556. Australia Narcotic Drugs Sales, by End-user N (2022-2027)
  • Table 557. Australia Narcotic Drugs Sales, by Material N (2022-2027)
  • Table 558. Rest of Asia-Pacific Narcotic Drugs Sales, by Type N (2022-2027)
  • Table 559. Rest of Asia-Pacific Narcotic Drugs Sales, by Types N (2022-2027)
  • Table 560. Rest of Asia-Pacific Narcotic Drugs Sales, by Distribution Channel N (2022-2027)
  • Table 561. Rest of Asia-Pacific Narcotic Drugs Sales, by End-user N (2022-2027)
  • Table 562. Rest of Asia-Pacific Narcotic Drugs Sales, by Material N (2022-2027)
  • Table 563. Europe Narcotic Drugs Sales, by Country N (2022-2027)
  • Table 564. Europe Narcotic Drugs Sales, by Type N (2022-2027)
  • Table 565. Europe Narcotic Drugs Sales, by Types N (2022-2027)
  • Table 566. Europe Narcotic Drugs Sales, by Distribution Channel N (2022-2027)
  • Table 567. Europe Narcotic Drugs Sales, by End-user N (2022-2027)
  • Table 568. Europe Narcotic Drugs Sales, by Material N (2022-2027)
  • Table 569. Germany Narcotic Drugs Sales, by Type N (2022-2027)
  • Table 570. Germany Narcotic Drugs Sales, by Types N (2022-2027)
  • Table 571. Germany Narcotic Drugs Sales, by Distribution Channel N (2022-2027)
  • Table 572. Germany Narcotic Drugs Sales, by End-user N (2022-2027)
  • Table 573. Germany Narcotic Drugs Sales, by Material N (2022-2027)
  • Table 574. France Narcotic Drugs Sales, by Type N (2022-2027)
  • Table 575. France Narcotic Drugs Sales, by Types N (2022-2027)
  • Table 576. France Narcotic Drugs Sales, by Distribution Channel N (2022-2027)
  • Table 577. France Narcotic Drugs Sales, by End-user N (2022-2027)
  • Table 578. France Narcotic Drugs Sales, by Material N (2022-2027)
  • Table 579. Italy Narcotic Drugs Sales, by Type N (2022-2027)
  • Table 580. Italy Narcotic Drugs Sales, by Types N (2022-2027)
  • Table 581. Italy Narcotic Drugs Sales, by Distribution Channel N (2022-2027)
  • Table 582. Italy Narcotic Drugs Sales, by End-user N (2022-2027)
  • Table 583. Italy Narcotic Drugs Sales, by Material N (2022-2027)
  • Table 584. United Kingdom Narcotic Drugs Sales, by Type N (2022-2027)
  • Table 585. United Kingdom Narcotic Drugs Sales, by Types N (2022-2027)
  • Table 586. United Kingdom Narcotic Drugs Sales, by Distribution Channel N (2022-2027)
  • Table 587. United Kingdom Narcotic Drugs Sales, by End-user N (2022-2027)
  • Table 588. United Kingdom Narcotic Drugs Sales, by Material N (2022-2027)
  • Table 589. Netherlands Narcotic Drugs Sales, by Type N (2022-2027)
  • Table 590. Netherlands Narcotic Drugs Sales, by Types N (2022-2027)
  • Table 591. Netherlands Narcotic Drugs Sales, by Distribution Channel N (2022-2027)
  • Table 592. Netherlands Narcotic Drugs Sales, by End-user N (2022-2027)
  • Table 593. Netherlands Narcotic Drugs Sales, by Material N (2022-2027)
  • Table 594. Rest of Europe Narcotic Drugs Sales, by Type N (2022-2027)
  • Table 595. Rest of Europe Narcotic Drugs Sales, by Types N (2022-2027)
  • Table 596. Rest of Europe Narcotic Drugs Sales, by Distribution Channel N (2022-2027)
  • Table 597. Rest of Europe Narcotic Drugs Sales, by End-user N (2022-2027)
  • Table 598. Rest of Europe Narcotic Drugs Sales, by Material N (2022-2027)
  • Table 599. MEA Narcotic Drugs Sales, by Country N (2022-2027)
  • Table 600. MEA Narcotic Drugs Sales, by Type N (2022-2027)
  • Table 601. MEA Narcotic Drugs Sales, by Types N (2022-2027)
  • Table 602. MEA Narcotic Drugs Sales, by Distribution Channel N (2022-2027)
  • Table 603. MEA Narcotic Drugs Sales, by End-user N (2022-2027)
  • Table 604. MEA Narcotic Drugs Sales, by Material N (2022-2027)
  • Table 605. Middle East Narcotic Drugs Sales, by Type N (2022-2027)
  • Table 606. Middle East Narcotic Drugs Sales, by Types N (2022-2027)
  • Table 607. Middle East Narcotic Drugs Sales, by Distribution Channel N (2022-2027)
  • Table 608. Middle East Narcotic Drugs Sales, by End-user N (2022-2027)
  • Table 609. Middle East Narcotic Drugs Sales, by Material N (2022-2027)
  • Table 610. Africa Narcotic Drugs Sales, by Type N (2022-2027)
  • Table 611. Africa Narcotic Drugs Sales, by Types N (2022-2027)
  • Table 612. Africa Narcotic Drugs Sales, by Distribution Channel N (2022-2027)
  • Table 613. Africa Narcotic Drugs Sales, by End-user N (2022-2027)
  • Table 614. Africa Narcotic Drugs Sales, by Material N (2022-2027)
  • Table 615. North America Narcotic Drugs Sales, by Country N (2022-2027)
  • Table 616. North America Narcotic Drugs Sales, by Type N (2022-2027)
  • Table 617. North America Narcotic Drugs Sales, by Types N (2022-2027)
  • Table 618. North America Narcotic Drugs Sales, by Distribution Channel N (2022-2027)
  • Table 619. North America Narcotic Drugs Sales, by End-user N (2022-2027)
  • Table 620. North America Narcotic Drugs Sales, by Material N (2022-2027)
  • Table 621. United States Narcotic Drugs Sales, by Type N (2022-2027)
  • Table 622. United States Narcotic Drugs Sales, by Types N (2022-2027)
  • Table 623. United States Narcotic Drugs Sales, by Distribution Channel N (2022-2027)
  • Table 624. United States Narcotic Drugs Sales, by End-user N (2022-2027)
  • Table 625. United States Narcotic Drugs Sales, by Material N (2022-2027)
  • Table 626. Canada Narcotic Drugs Sales, by Type N (2022-2027)
  • Table 627. Canada Narcotic Drugs Sales, by Types N (2022-2027)
  • Table 628. Canada Narcotic Drugs Sales, by Distribution Channel N (2022-2027)
  • Table 629. Canada Narcotic Drugs Sales, by End-user N (2022-2027)
  • Table 630. Canada Narcotic Drugs Sales, by Material N (2022-2027)
  • Table 631. Mexico Narcotic Drugs Sales, by Type N (2022-2027)
  • Table 632. Mexico Narcotic Drugs Sales, by Types N (2022-2027)
  • Table 633. Mexico Narcotic Drugs Sales, by Distribution Channel N (2022-2027)
  • Table 634. Mexico Narcotic Drugs Sales, by End-user N (2022-2027)
  • Table 635. Mexico Narcotic Drugs Sales, by Material N (2022-2027)
  • Table 636. Narcotic Drugs: by Type(USD/Units)
  • Table 637. Research Programs/Design for This Report
  • Table 638. Key Data Information from Secondary Sources
  • Table 639. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Narcotic Drugs: by Type USD Million (2016-2021)
  • Figure 5. Global Narcotic Drugs: by Types USD Million (2016-2021)
  • Figure 6. Global Narcotic Drugs: by Distribution Channel USD Million (2016-2021)
  • Figure 7. Global Narcotic Drugs: by End-user USD Million (2016-2021)
  • Figure 8. Global Narcotic Drugs: by Material USD Million (2016-2021)
  • Figure 9. South America Narcotic Drugs Share (%), by Country
  • Figure 10. Asia Pacific Narcotic Drugs Share (%), by Country
  • Figure 11. Europe Narcotic Drugs Share (%), by Country
  • Figure 12. MEA Narcotic Drugs Share (%), by Country
  • Figure 13. North America Narcotic Drugs Share (%), by Country
  • Figure 14. Global Narcotic Drugs: by Type N (2016-2021)
  • Figure 15. Global Narcotic Drugs: by Types N (2016-2021)
  • Figure 16. Global Narcotic Drugs: by Distribution Channel N (2016-2021)
  • Figure 17. Global Narcotic Drugs: by End-user N (2016-2021)
  • Figure 18. Global Narcotic Drugs: by Material N (2016-2021)
  • Figure 19. South America Narcotic Drugs Share (%), by Country
  • Figure 20. Asia Pacific Narcotic Drugs Share (%), by Country
  • Figure 21. Europe Narcotic Drugs Share (%), by Country
  • Figure 22. MEA Narcotic Drugs Share (%), by Country
  • Figure 23. North America Narcotic Drugs Share (%), by Country
  • Figure 24. Global Narcotic Drugs: by Type USD/Units (2016-2021)
  • Figure 25. Global Narcotic Drugs share by Players 2021 (%)
  • Figure 26. Global Narcotic Drugs share by Players (Top 3) 2021(%)
  • Figure 27. Global Narcotic Drugs share by Players (Top 5) 2021(%)
  • Figure 28. BCG Matrix for key Companies
  • Figure 29. Johnson & Johnson (United States) Revenue, Net Income and Gross profit
  • Figure 30. Johnson & Johnson (United States) Revenue: by Geography 2021
  • Figure 31. Roche (Switzerland) Revenue, Net Income and Gross profit
  • Figure 32. Roche (Switzerland) Revenue: by Geography 2021
  • Figure 33. Novartis Ag (Switzerland) Revenue, Net Income and Gross profit
  • Figure 34. Novartis Ag (Switzerland) Revenue: by Geography 2021
  • Figure 35. Merck & Co. (United States) Revenue, Net Income and Gross profit
  • Figure 36. Merck & Co. (United States) Revenue: by Geography 2021
  • Figure 37. Pfizer (United States) Revenue, Net Income and Gross profit
  • Figure 38. Pfizer (United States) Revenue: by Geography 2021
  • Figure 39. Merck (United States) Revenue, Net Income and Gross profit
  • Figure 40. Merck (United States) Revenue: by Geography 2021
  • Figure 41. Glaxosmithkline (United Kingdom) Revenue, Net Income and Gross profit
  • Figure 42. Glaxosmithkline (United Kingdom) Revenue: by Geography 2021
  • Figure 43. Sanofi (Paris) Revenue, Net Income and Gross profit
  • Figure 44. Sanofi (Paris) Revenue: by Geography 2021
  • Figure 45. Sun Pharma (India) Revenue, Net Income and Gross profit
  • Figure 46. Sun Pharma (India) Revenue: by Geography 2021
  • Figure 47. Glaxosmithkline Australia Pty Ltd. (Australia) Revenue, Net Income and Gross profit
  • Figure 48. Glaxosmithkline Australia Pty Ltd. (Australia) Revenue: by Geography 2021
  • Figure 49. Global Narcotic Drugs: by Type USD Million (2022-2027)
  • Figure 50. Global Narcotic Drugs: by Types USD Million (2022-2027)
  • Figure 51. Global Narcotic Drugs: by Distribution Channel USD Million (2022-2027)
  • Figure 52. Global Narcotic Drugs: by End-user USD Million (2022-2027)
  • Figure 53. Global Narcotic Drugs: by Material USD Million (2022-2027)
  • Figure 54. South America Narcotic Drugs Share (%), by Country
  • Figure 55. Asia Pacific Narcotic Drugs Share (%), by Country
  • Figure 56. Europe Narcotic Drugs Share (%), by Country
  • Figure 57. MEA Narcotic Drugs Share (%), by Country
  • Figure 58. North America Narcotic Drugs Share (%), by Country
  • Figure 59. Global Narcotic Drugs: by Type N (2022-2027)
  • Figure 60. Global Narcotic Drugs: by Types N (2022-2027)
  • Figure 61. Global Narcotic Drugs: by Distribution Channel N (2022-2027)
  • Figure 62. Global Narcotic Drugs: by End-user N (2022-2027)
  • Figure 63. Global Narcotic Drugs: by Material N (2022-2027)
  • Figure 64. South America Narcotic Drugs Share (%), by Country
  • Figure 65. Asia Pacific Narcotic Drugs Share (%), by Country
  • Figure 66. Europe Narcotic Drugs Share (%), by Country
  • Figure 67. MEA Narcotic Drugs Share (%), by Country
  • Figure 68. North America Narcotic Drugs Share (%), by Country
  • Figure 69. Global Narcotic Drugs: by Type USD/Units (2022-2027)
Some of the key companies/manufacturers profiled in the report
  • Johnson & Johnson (United States)
  • Roche (Switzerland)
  • Novartis Ag (Switzerland)
  • Merck & Co. (United States)
  • Pfizer (United States)
  • Merck (United States)
  • Glaxosmithkline (United Kingdom)
  • Sanofi (Paris)
  • Sun Pharma (India)
  • Glaxosmithkline Australia Pty Ltd. (Australia)
Additional players considered in the study are as follows:
Celanese Chemicals (United States) , Bedoukian Research Inc. (United States) , Eastman Chemical Company. (United States)
Select License Type
Sample Report Enquiry Before Buy Request Discount

Speak with Analyst

Want to find out more about this report?

Get Free Consultation